OP0174 Efficacy and Safety of Ustekinumab in Psoriatic Arthritis Patients with Spondylitis and Peripheral Joint Involvement: Results from a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study

A Kavanaugh,P Rahman,I Mcinnes,Y You,Y Wang,A.B Gottlieb,C Ritchlin,M Song,L Puig,A.M Mendelsohn

doi:10.1136/annrheumdis-2015-eular.3096

OP0174 Efficacy and Safety of Ustekinumab in Psoriatic Arthritis Patients with Spondylitis and Peripheral Joint Involvement: Results from a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study

A Kavanaugh, P Rahman + Show 8 more

https://doi.org/10.1136/annrheumdis-2015-eular.3096

Copy DOI

Journal: Annals of the Rheumatic Diseases	Publication Date: Jun 1, 2015
Citations: 3

Affiliation: University of California, San Diego, Memorial University of Newfoundland, University of Glasgow, Janssen (United States), University of Rochester, Autonomous University of Barcelona

#Peripheral Joint Involvement #Proportion Of Pts + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

BackgroundIL-23 may be implicated in spondylitis. A substantial number of pts with spondylitis and peripheral joint involvement were enrolled in PSUMMIT.ObjectivesWe evaluated the efficacy of SC UST 45/90 mg in...

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Annals of the Rheumatic Diseases

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.